Detection and characterization of N-glycolyated gangliosides in Wilms tumor by immunohistochemistry

Pediatric and Developmental Pathology

Volumn 13, Issue 1, 2010, Pages 18-23

  Scursoni, Alejandra M ^a   Galluzzo, Laura ^a   Camarero, Sandra ^a   Pozzo, Norma ^a   Gabri, Mariano R ^b   De Acosta, Cristina Mateo ^c   Vázquez, Ana María ^c   Alonso, Daniel F ^b   De Davila, María Teresa G ^a  

^a Garrahan Pediatrics Hospital   (Argentina)

^b UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

^c CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

Author keywords

Gangliosides; GM3; Immunohistochemistry; Immunotherapy; N glycolyl neuraminic acid; Nephroblastoma

Indexed keywords

DACTINOMYCIN; GANGLIOSIDE; GANGLIOSIDE GM3; GLYCOLIPID; MONOCLONAL ANTIBODY; N GLYCOLOYLNEURAMINIC ACID; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CHILD; CLINICAL ARTICLE; DRUG TARGETING; FETUS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY; NEPHROBLASTOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOLID TUMOR; TUMOR DIAGNOSIS;

ANIMALS; CELL MEMBRANE; COMBINED MODALITY THERAPY; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; G(M3) GANGLIOSIDE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MICE; RETROSPECTIVE STUDIES; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL; WILMS TUMOR;

EID: 77949739944     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/08-10-0544.1     Document Type: Article

References (32)

1. Bitton RJ, Guthmann MD, Gabri MR, et al. Cancer vaccines: an update with special focus on ganglioside antigens. Oncol Rep 2002; 9:267-276.
2. Patra SK. Dissecting lipid raft facilitated cell signaling pathways in cancer. Biochim Biophys Acta 2008;1785:182-206.
3. Hakomori S, Kannagi R. Glycosphingolipids tumor-associated and differentiation markers: a guest editorial. J Natl Cancer Inst 1983; 71:231-251.
4. Schlenzka W, Shaw L, Kelm S, et al. CMP-N-acetylneuraminic acid hydroxylase: the first cytosolic Rieske iron-sulphur protein to be described in Eukarya. FEBS Lett 1996;385:197-200.
5. Irie A, Suzuki A. CMP-N-acetylneuraminic acid hydrolase is exclusively inactive in humans. Biochem Biophys Res Comun 1998;248:330-333.
6. Tangvoranuntakul P, Gagneux P, Diaz S, et al. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. PNAS 2003;100:12045-12050.
7. Marquina G, Waki H, Fernandez LE, et al. Gangliosides expressed in human breast cancer. Cancer Res 1996;56:5165-5171.
8. Carr A, Mullet A, Mazorra Z, et al. Mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors. Hybridoma 2000;19:241-247.
9. Fernandez LE, Alonso DF, Gomez DE, Vazquez AM. Gangliosidebased vaccines and anti-idiotype antibodies for active immunotherapy against cancer. Expert Rev Vaccines 2003;2:817-823.
10. Kannagi R, Yin J, Miyazaki K, Izawa M. Current relevance of incomplete synthesis and neo-synthesis for cancer-associated alteration of carbohydrate determinants-Hakomori's concepts revisited. Biochem Biophys Acta 2008;1780:525-531.
11. Yin J, Hashimoto A, Izawa M, et al. Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells. Cancer Res 2006;66:2937-2945.
12. Sakakibara N, Gasa S, Kamio K, et al. Distinctive glycolipid patterns in Wilms' tumor and renal cell carcinoma. Cancer Lett 1991;57:187-192.
13. Kaste SC,DomeJS, Babyn PS, et al. Wilmstumour: prognostic factors, staging, therapy and late effects. Pediatr Radiol 2008;38:2-17.
14. Vázquez AM, Gabri MR, Hernández AM, et al. Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides. Oncol Rep 2000;7:751-756.
15. Diaz A, Alfonso M, Alonso R, et al. Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides. Clin Immunol 2003;107:80-89.
16. Guthmann MD, Castro MA, Cinat G, et al. Cellular and humoral immune response to N-glycolyl-GM3 elicited by prolonged immunotherapy with an anti-idiotypic vaccine in high-risk and metastatic breast cancer patients. J Immunother 2006;29:215-223.
17. Alfonso M, Diaz A, Hernandez AM, et al. An anti-idiotype vaccine elicits a specific response to N-glycolyl sialic acid residues of glycoconjugates in melanoma patients. J Immunol 2002;168:2523-2529.
18. Alfonso S, D?́az RM, De la Torre A, et al. 1E10 anti-idiotype vaccine in non-small cell lung cancer: experience in stage IIIb/IV patients. Cancer Biol Ther 2008;6:1847-1852.
19. Ramani P, Cowell JK. The expression pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours. J Pathol 1996;179:162-168.
20. Hazen-Martin DJ, Re GG, Garvin AJ, Sens DA. Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line. Am J Pathol 1994;144:1023-1034.
21. Quinlan DC, Davidson AG, Summers CL. Accumulation of p53 protein correlates with poor prognosis in human lung cancer. Cancer Res 1992;52:4828-4831.
22. Sredni ST, Camargo B, Lopes LF, Teixeira R, Simpson A. Immunohistochemical detection of p53 protein expression as a prognostic indicator in Wilms tumor. Med Pediatr Oncol 2001;37: 455-458.
23. Vujanic GM, Sandstedt B, Harms D, et al. Revised International Society of Pediatric Oncology (SIOP) working classification of renal tumors of childhood. Med Pediatr Oncol 2002;38:79-82.
24. Alonso DF, Gabri MR, Guthmann MD, Fainboim L, Gomez DE. A novel hydrophobized GM3 ganglioside/Neisseria meningitidis outer membrane protein complex vaccine induces tumor protection in B16 murine melanoma. Int J Oncol 1999;15:59-66.
25. Simons K, van Meer G. Lipid sorting in epithelial cells. Biochemistry 1988;27:6197-6202.
26. Vazquez AM, Alfonso M, Karlsson A, et al. Generation of a murine monoclonal antibody specific for N-glycolylneuraminic acid containing gangliosides that also recognizes sulfated glycolipids. Hybridoma 1995;14:551-556.
27. Lauc G, Heffer-Lauc M. Shedding and uptake of gangliosides and glycosylphosphatidylinositol-anchored proteins. Biochim Biophys Acta 2006;1760:584-602.
28. Varki NM, Varki A. Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab Invest 2007;87:851-857.
29. Malykh YN, Schauer R, Shaw L. N-glycolylneuraminic acid in human tumours. Biochimie 2001;83:623-634.
30. Hill DA, Shear TD, Liu T, Billups CA, Singh PK, Dome JS. Clinical and biologic significance of nuclear unrest in Wilms tumor. Cancer 2003; 97:2318-2326.
31. Vujanic GM, Harms D, Sandstedt B, Weirich A, de Kraker J, Delemarre JF. New definitions of focal and diffuse anaplasia in Wilms tumor: the International Society of Paediatric Oncology (SIOP) experience. Med Pediatr Oncol 1999;32:317-323.
32. Livingston PO. Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccines. Immunol Rev 1995;145:147-166.